FB
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP)
NASDAQ·Technology·General
$16.00
-1.23%
Mkt Cap $107.61M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$230.00
Range $156.00 – $270.00
Implied Upside
+1337.5%
Consensus $230.00 vs current $16.00